Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages 343-345

  Campo, Gianluca ^a,b   Punzetti, Silvia ^a   Malagù, Michele ^a   Ferrari, Roberto ^a,b,c   Valgimigli, Marco ^d  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b LTTA Center   (Italy)

^c MARIA CECILIA HOSPITAL   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Drug eluting stent; In stent restenosis; Percutaneous coronary intervention; Target lesion failure

Indexed keywords

EVEROLIMUS; PACLITAXEL; ZOTAROLIMUS;

AGED; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; LETTER; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED;

EID: 84898875553     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.028     Document Type: Article

References (7)

1. B. Scheller, Y.P. Clever, and B. Kelsch et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
2. A. Kastrati, J. Mehilli, and N. von Beckerath et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
3. G. Richardt, M. Leschke, and M. Abdel-Wahab et al. Clinical outcomes of the resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis JACC Cardiovasc Interv 6 2013 905 913
4. M. Valgimigli, G. Campo, and G. Percoco et al. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: design and rationale for the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY) Am Heart J 160 2010 804 811
5. M. Valgimigli, G. Campo, and M. Monti et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 16 Apr 24 2012 2015 2026
6. G. Campo, M. Tebaldi, and P. Vranckx et al. Short vs. long term duration of dual antiplatelet therapy in patients treated for in-stent restenosis. A PRODIGY trial substudy J Am Coll Cardiol 63 6 2014 506 512
7. M. Valgimigli, M. Tebaldi, and M. Borghesi et al. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study JACC Cardiovasc Interv 7 1 2014 20 28